Question

Difficulty: HardLabor, Delivery, and Puerperium

Match each clinical vignette describing an adverse reaction during the management of postpartum hemorrhage to the underlying mechanism of action of the responsible pharmacologic agent.

  • A 29-year-old woman with uterine atony develops severe wheezing, dyspnea, and oxygen desaturation to 88% immediately after intramuscular administration of a uterotonic agent.Synthetic prostaglandin F2-alpha analog that stimulates uterine contractility but also causes significant bronchial smooth muscle constriction.
  • A 34-year-old woman with chronic hypertension receives a second-line medication for postpartum hemorrhage and subsequently experiences a severe hypertensive crisis (190/115 mmHg) and a throbbing headache.Ergot alkaloid that induces tetanic uterine contractions and causes potent systemic vasoconstriction via partial alpha-adrenergic and serotonergic agonism.
  • A 26-year-old woman receiving a prolonged, high-dose intravenous infusion of a first-line uterotonic agent develops lethargy, confusion, and a generalized tonic-clonic seizure associated with a serum sodium level of 116 mEq/L.Endogenous nonapeptide hormone analog that stimulates uterine contractions but exhibits cross-reactivity with renal V2 receptors, promoting free water retention.
  • A 31-year-old woman treated for refractory postpartum hemorrhage complains of severe, sudden-onset diarrhea, nausea, and a transient fever of 38.6°C (101.5°F) shortly after rectal administration of a uterotonic.Synthetic prostaglandin E1 analog that enhances uterine contractility but frequently causes gastrointestinal smooth muscle stimulation and alters the hypothalamic thermoregulatory set point.

Answer

The left clinical vignettes match to their right pharmacologic mechanisms as follows: wheezing matches the PGF2-alpha analog, hypertension matches the ergot alkaloid, hyponatremia matches the nonapeptide hormone analog, and diarrhea/fever matches the PGE1 analog.
Each uterotonic agent has a distinct mechanism of action corresponding directly to its side effect profile. Carboprost (PGF2-alpha) causes bronchospasm. Methylergonovine (ergot alkaloid) causes vasoconstriction and systemic hypertension. Oxytocin (ADH analog) causes water retention and subsequent hyponatremia. Misoprostol (PGE1) causes GI stimulation and fever.

Step-by-Step Solution

1
Analyze the first vignette describing respiratory distress after an intramuscular uterotonic.
Identified as carboprost-induced bronchospasm.
Carboprost is a prostaglandin F2-alpha analog known to cause smooth muscle constriction in both the uterus and airways.
2
Analyze the second vignette describing a hypertensive crisis and headache after uterotonic administration.
Identified as methylergonovine-induced hypertension.
Methylergonovine is an ergot alkaloid that causes potent peripheral vasoconstriction.
3
Analyze the third vignette describing seizures and hyponatremia during a prolonged intravenous infusion.
Identified as oxytocin-induced water intoxication.
Oxytocin is a nonapeptide structurally similar to ADH, causing cross-reactivity at V2 receptors leading to dilutional hyponatremia.
4
Analyze the fourth vignette describing diarrhea and fever after rectal administration.
Identified as misoprostol-induced GI distress and pyrexia.
Misoprostol is a PGE1 analog that stimulates gastrointestinal smooth muscle and alters temperature regulation.

Key Concept

Pharmacologic mechanisms and characteristic adverse effects of uterotonic agents used in postpartum hemorrhage
Estimated Time:1m 30s
Rate this question